Inventor · disambiguated record
Nathan Genung
Also filed as: GENUNG NATHAN · GENUNG NATHAN E · GENUNG NATHAN EDWARD
8 granted patents·9 pending applications·0 citations·filing 2017–2025
73Inventor score
Top patents by PatentIndex Score
17 records- 0180US12275728B2O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitorsBIOGEN MA INC·Filed 2024·Granted Apr 15, 2025·0 cites·2 claims
- 0279US2025034136A1Wrn inhibitorsNIMBUS WADJET INC·Filed 2024·Application pending·0 cites
- 0370US12421233B2WRN inhibitorsNIMBUS WADJET INC·Filed 2025·Granted Sep 23, 2025·0 cites·20 claims
- 0470US12344609B2WRN inhibitorsNIMBUS WADJET INC·Filed 2025·Granted Jul 1, 2025·0 cites·26 claims
- 0563US2025206738A1Wrn inhibitorsNIMBUS WADJET INC·Filed 2024·Application pending·0 cites
- 0662US2025129069A1Triazolo wrn inhibitorsNIMBUS WADJET INC·Filed 2024·Application pending·0 cites
- 0760US2025387400A1Tyk2 inhibitorsBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 0860US2025304577A1Tyk2 inhibitorsBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 0957US12180205B2O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitorsBIOGEN MA INC·Filed 2019·Granted Dec 31, 2024·0 cites·20 claims
- 1057US2023117898A1O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1152US2024360157A1Tyk2 inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1251US2025368646A1Tricyclic fused wrn inhibitorsNIMBUS WADJET INC·Filed 2025·Application pending·0 cites
- 1350US12421224B2Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitorsBIOGEN MA INC·Filed 2020·Granted Sep 23, 2025·0 cites·20 claims
- 1448US11459324B2O-glycoprotein-2-acetamido-2-deoxy-3-D-glycopyranosidase inhibitorsBIOGEN MA INC·Filed 2019·Granted Oct 4, 2022·0 cites·21 claims
- 1546US12319679B2Morpholinyl, piperazinyl, oxazepanyl and diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitorsBIOGEN MA INC·Filed 2019·Granted Jun 3, 2025·0 cites·18 claims
- 1645US2022290140A1Trans-cyclooctene labeled antisense oligonucleotides, radio labeled tetrazine and methodsBIOGEN MA INC·Filed 2020·Application pending·0 cites
- 1742US11427561B2IRAK4 inhibiting agentsBIOGEN MA INC·Filed 2017·Granted Aug 30, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Nathan Genung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →